Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke "WAKE-UP"
Not yet recruiting
Phase 3 Results N/ASummary of Purpose
WAKE-UP is an investigator initiated European multicenter randomized controlled clinical trial of MRI based thrombolysis in acute stroke patients with unknown time of symptom onset, e.g. due to recognition of stroke symptoms on awakening. Objective of WAKE-UP is to prove efficacy and safety of MRI-based intravenous thrombolysis with Alteplase in patients waking up with stroke symptoms or patients with otherwise...
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 1 February 2012.
| 1 Jun 2012 | 30 Jan 2012 | 1 May 2016 | 1 May 2016 | 1 Jan 2012 | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Basics
Interventions
Conditions
Sponsors
Trial Design
- Allocation: Randomized
- Masking: Double Blind (Subject, Investigator)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
Contacts
Not available
View Trial Locations
Recruitment
- Enrollment: 800
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 7 locations, 6 countries
Principal Investigator
- Goetz Thomalla, MD
